网友提问：
云南白药(000538)
最新MSCT的云南白药研究报告
网友回复
傻丫一枚：
It is expected that the Company will expand the growth margin of the company by 2018 - 2020 EPS of 3.5 , 3.78 and 4.98 yuan , the company as the leading white horse for Chinese medicine consumption , the controlling mix - up and the final landing of high - tube incentive optimization , and it is expected to continue to improve the company ' s valuation premium and maintain " buy " rating .
妙桃娇姬：
一瞬间待爆发：
看你发些日文干嘛啦？